Gastro-esophageal Reflux Disease (GERD) Completed Phase 4 Trials for Rabeprazole (DB01129)

Also known as: Gastroesophageal Reflux Disease / Gastro-esophageal Reflux Disease / GERD / GERD Gastroesophageal Reflux Disease / Gastro-Oesophageal Reflux Disease / Gastrooesophageal reflux disease / GERD (Gastroesophageal Reflux Disease) / Esophageal Reflux / GERD - Gastro-Esophageal Reflux Disease / Gastroesophageal Reflux Disease (GERD) / Gastro-esophageal Reflux Diseases / Oesophageal reflux / Esophagitis / Gastrooesophageal reflux / Gastroesophageal reflux / Esophageal reflux NOS

IndicationStatusPhase
DBCOND0077290 (Gastro-esophageal Reflux Disease (GERD))Completed4
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00251732Role of Pain Modulation in GERD Patients Who Failed Standard Dose Proton Pump Inhibitors (PPI)Treatment
NCT00304421Comparison of the Nighttime Effects of Two Different Drugs on Subjects With GERDTreatment
NCT00287391Sleep Disorders and Gastroesophageal Reflux Disease (GERD)Treatment
NCT00354757CYP2C19 Genetic Polymorphism on the Accuracy of Proton-Pump Inhibitor TestingDiagnostic